Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2019 1
2020 5
2021 2
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging.
Houvast RD, Vankemmelbeke M, Durrant LG, Wuhrer M, Baart VM, Kuppen PJK, de Geus-Oei LF, Vahrmeijer AL, Sier CFM. Houvast RD, et al. Among authors: baart vm. Cancers (Basel). 2020 Dec 21;12(12):3870. doi: 10.3390/cancers12123870. Cancers (Basel). 2020. PMID: 33371487 Free PMC article. Review.
uPAR directed-imaging of head-and-neck cancer.
Baart VM, Boonstra MC, Sier CFM. Baart VM, et al. Oncotarget. 2017 Mar 28;8(13):20519-20520. doi: 10.18632/oncotarget.16240. Oncotarget. 2017. PMID: 28423554 Free PMC article. No abstract available.
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas.
Peng L, Li Y, Yao S, Gaedcke J, Baart VM, Sier CFM, Neesse A, Ellenrieder V, Bohnenberger H, Fuchs F, Kitz J, Ströbel P, Küffer S. Peng L, et al. Among authors: baart vm. Cancers (Basel). 2023 Mar 3;15(5):1587. doi: 10.3390/cancers15051587. Cancers (Basel). 2023. PMID: 36900379 Free PMC article.
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.
de Geus SW, Baart VM, Boonstra MC, Kuppen PJ, Prevoo HA, Mazar AP, Bonsing BA, Morreau H, van de Velde CJ, Vahrmeijer AL, Sier CF. de Geus SW, et al. Among authors: baart vm. Biomark Insights. 2017 Jun 22;12:1177271917715443. doi: 10.1177/1177271917715443. eCollection 2017. Biomark Insights. 2017. PMID: 28690396 Free PMC article. Review.
Anti-GD2-IRDye800CW as a targeted probe for fluorescence-guided surgery in neuroblastoma.
Wellens LM, Deken MM, Sier CFM, Johnson HR, de la Jara Ortiz F, Bhairosingh SS, Houvast RD, Kholosy WM, Baart VM, Pieters AMMJ, de Krijger RR, Molenaar JJ, Wehrens EJ, Dekkers JF, Wijnen MHWA, Vahrmeijer AL, Rios AC. Wellens LM, et al. Among authors: baart vm. Sci Rep. 2020 Oct 19;10(1):17667. doi: 10.1038/s41598-020-74464-4. Sci Rep. 2020. PMID: 33077751 Free PMC article.
[Optimal timing of a hip fracture operation].
Voeten SC, Baart VM, Krijnen P, Schipper IB. Voeten SC, et al. Among authors: baart vm. Ned Tijdschr Geneeskd. 2019 Jan 29;163:D2911. Ned Tijdschr Geneeskd. 2019. PMID: 30719881 Dutch.
Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
Baart VM, van Manen L, Bhairosingh SS, Vuijk FA, Iamele L, de Jonge H, Scotti C, Resnati M, Cordfunke RA, Kuppen PJK, Mazar AP, Burggraaf J, Vahrmeijer AL, Sier CFM. Baart VM, et al. Mol Imaging Biol. 2023 Feb;25(1):122-132. doi: 10.1007/s11307-021-01657-2. Epub 2021 Oct 12. Mol Imaging Biol. 2023. PMID: 34642899 Free PMC article.
Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer.
Vuijk FA, Kleiburg F, Noortman WA, Heijmen L, Feshtali Shahbazi S, van Velden FHP, Baart VM, Bhairosingh SS, Windhorst BD, Hawinkels LJAC, Dibbets-Schneider P, Bouwman N, Crobach SALP, Fariña-Sarasqueta A, Marinelli AWKS, Oprea-Lager DE, Swijnenburg RJ, Smit F, Vahrmeijer AL, de Geus-Oei LF, Hilling DE, Slingerland M. Vuijk FA, et al. Among authors: baart vm. Cancers (Basel). 2022 Dec 15;14(24):6209. doi: 10.3390/cancers14246209. Cancers (Basel). 2022. PMID: 36551695 Free PMC article.
Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.
Houvast RD, Baart VM, Bhairosingh SS, Cordfunke RA, Chua JX, Vankemmelbeke M, Parsons T, Kuppen PJK, Durrant LG, Vahrmeijer AL, Sier CFM. Houvast RD, et al. Among authors: baart vm. Mol Imaging Biol. 2020 Dec;22(6):1511-1522. doi: 10.1007/s11307-020-01522-8. Epub 2020 Aug 11. Mol Imaging Biol. 2020. PMID: 32780212 Free PMC article.
14 results